MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enna, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enna, S. J.
Molecular Interventions 1:208-218 (2001)
© 2001 American Society of Pharmacology and Experimental Therapeutics


Review

A GABAB Mystery: The Search for Pharmacologically Distinct GABAB Receptors

S. J. Enna

Department of Pharmacology, Toxicology and Therapeutics Kansas University School of Medicine 3901 Rainbow Blvd., Kansas City, Kansas 66160.


The preponderance of GABAergic activity in rat brain is revealed by in situ hybridization of mRNA that encodes the GABABR1 receptor. The development of drugs that can usefully modulate GABAB receptor activity hinges in part on efforts to identify and target pharmacologically distinguishable receptor subtypes.

[Image courtesy of Nature (www.nature.com) and B. Bettler. Nature 386, 239–246 (1997)]

The classification of neurotransmitter receptors into distinct pharmacological subtypes is of major importance in drug discovery. This quest is particularly important for neurotransmitter systems that are widely distributed. Because {gamma}-aminobutyric acid (GABA) receptors, both GABAA and GABAB, are found throughout the neuroaxis, they are likely involved in all central nervous system functions. Accordingly, the therapeutic promise of GABAB receptor manipulation depends upon the identification of subtypes than can be specifically targeted.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
O. J. Ariwodola and J. L. Weiner
Ethanol Potentiation of GABAergic Synaptic Transmission May Be Self-Limiting: Role of Presynaptic GABAB Receptors
J. Neurosci., November 24, 2004; 24(47): 10679 - 10686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Balasubramanian, J. A. Teissere, D. V. Raju, and R. A. Hall
Hetero-oligomerization between GABAA and GABAB Receptors Regulates GABAB Receptor Trafficking
J. Biol. Chem., April 30, 2004; 279(18): 18840 - 18850.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. A. Sands, K. E. McCarson, and S. J. Enna
Differential Regulation of GABAB Receptor Subunit Expression and Function
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 191 - 196.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.